November 16, 2026 – New research into visual processing, brain activity and the biology of Visual Snow Syndrome is raising important questions. But which developments represent genuine progress, and which studies are open to participants? We examine the latest research, what it could mean for patients and where to find out more.
Why does visual snow remain constantly visible? Could the brains of people with Visual Snow Syndrome (VSS) process visual information differently? And might scientists eventually identify measurable neurological changes that could help improve diagnosis or guide treatment?
These questions are at the centre of several research projects currently taking place internationally.
In London, scientists are investigating how the brain filters visual information, using experiments that include augmented reality. In Minnesota, researchers are examining visual adaptation and its relationship to brain activity. Meanwhile, another team at King’s College London has completed data collection for a study investigating whether VSS has a distinct pattern of neurological activity.
For people living with VSS, however, the significance of these studies is not always immediately clear. Some investigate possible mechanisms behind the condition, while others explore methods that could eventually improve diagnosis. None of the studies discussed here has established a cure or a proven new treatment.
There are also practical limitations. Many research projects require participants to travel to specialised facilities, sometimes abroad. Others have strict eligibility requirements or are no longer recruiting. For patients whose symptoms significantly restrict their ability to travel, participation may not be realistic.
So what is actually happening in VSS research in 2026, and which developments deserve attention?
1. London: Can scientists measure how the brain filters visual noise?
King’s College London, United Kingdom
One of the more recent opportunities for patients to contribute to research is the VISIONS study at King’s College London.
The project investigates how people with VSS process visual information, particularly how the brain filters visual noise.
Under normal circumstances, the visual system continuously processes and prioritises information. Researchers are interested in whether aspects of this processing differ in people who experience persistent visual snow.
The study uses computer-based visual tasks involving moving patterns. Participants with VSS also use augmented reality (AR) to adjust a simulation of visual snow until it resembles their own experience.
This is particularly interesting because visual snow is inherently subjective. Two people may describe similar symptoms while experiencing them differently. Developing methods to characterise these experiences more precisely could improve how symptoms are measured in future studies.
The researchers are also investigating possible relationships between VSS, visual imagery and synaesthesia, a phenomenon in which stimulation of one sensory or cognitive pathway produces an additional involuntary experience.
Why does this matter?
A major challenge in VSS research is that there is currently no established objective diagnostic biomarker. Diagnosis relies on clinical criteria and the symptoms reported by patients.
Research that allows scientists to measure and compare aspects of visual perception could eventually contribute to more reliable assessment methods.
However, the VISIONS study is investigating visual processing, not testing a treatment.
Interested in participating?
The published study information invites adults with VSS and healthy volunteers who meet the eligibility criteria.
Participation involves one visit of approximately 90 minutes in London. The researchers provide breaks between tasks, and participants can request additional breaks or stop if they feel uncomfortable.
The visual experiments may temporarily increase symptoms or cause eyestrain, dizziness or headaches in some participants.
According to the study information, participants receive £25 for their time. Anyone travelling from abroad should confirm whether recruitment remains open and whether travel expenses are covered before making arrangements.
Study information: VISIONS – King’s College London
Contact: vs-research@kcl.ac.uk
2. Minnesota: What happens when the visual system adapts to what we see?
University of Minnesota, United States
Another research project is examining a fundamental feature of vision: visual adaptation.
Our visual system does not respond to every stimulus in exactly the same way indefinitely. When we are exposed to certain visual patterns for an extended period, our perception and sensitivity can change.
This process helps scientists understand how the visual system responds to ongoing stimulation.
Researchers at the University of Minnesota want to investigate whether visual adaptation differs in people with VSS and how these differences relate to brain function.
The study combines behavioural assessments and visual experiments with functional MRI and magnetic resonance spectroscopy.
These techniques allow researchers to investigate both visual performance and aspects of brain activity and neurochemistry.
Why does this matter?
One possibility being investigated in VSS research is that persistent visual symptoms are associated with differences in the way visual signals are generated or processed.
Studying adaptation may help researchers test specific hypotheses about those processes.
Importantly, visual adaptation experiments do not automatically reveal why VSS develops. Researchers must establish whether any observed differences are specific to VSS, reproducible and meaningfully related to symptoms.
The study is therefore primarily aimed at understanding mechanisms rather than offering symptom relief.
Interested in participating?
The University of Minnesota currently lists the study as recruiting.
The research includes adults with VSS aged 18–60 who meet additional health and eligibility requirements.
However, geographical restrictions apply to the VSS participant group. The published research information indicates that participants must live within approximately two hours of the study location.
For most international patients, participation is therefore unlikely to be feasible.
Study information: University of Minnesota – Visual Perception in Visual Snow Syndrome
Contact: schallmolab@umn.edu
3. London: Could VSS have a measurable neurological signature?
King’s College London, United Kingdom
While some studies are recruiting participants, others have reached an important stage: data collection is complete, and researchers are now analysing their findings.
One such project is being conducted at King’s College London by a research group involving Dr Francesca Puledda, Professor Peter Goadsby and their colleagues.
The team is using transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) to investigate how the brain responds to stimulation.
TMS delivers magnetic pulses to targeted areas of the brain, while EEG records the resulting electrical activity.
Researchers have collected data from three groups: people with VSS, people with migraine and healthy participants.
According to the research update published in August 2026, data collection has been completed. Analysis is underway, with a scientific publication planned for submission in late 2026 or early 2027.
Why does this matter?
VSS frequently occurs alongside migraine, but the two are distinct conditions.
Researchers want to determine whether VSS has a recognisable neurophysiological profile and whether that profile differs from patterns associated with migraine.
If reproducible differences are identified, they could contribute to the search for neurological biomarkers.
However, a potential biomarker would need to be validated in larger, independent patient groups before it could be considered useful in clinical practice.
The important development here is that the study has moved from data collection to analysis. Its findings have not yet been published, so no conclusions about the results can be drawn.
Research update: King’s College London – 2026 Research Report
4. What about GABA, glutamate and future treatment targets?
King’s College London, United Kingdom
Another research direction at King’s College London focuses on the balance between excitatory and inhibitory signalling in the brain.
Two neurotransmitters are of particular interest: glutamate, the brain’s principal excitatory neurotransmitter, and GABA, an important inhibitory neurotransmitter.
Researchers are investigating whether changes in these systems could contribute to the neurological mechanisms underlying VSS.
Using advanced 7-tesla MRI and magnetic resonance spectroscopy, the team aims to examine aspects of brain metabolism and neurotransmitter concentrations.
According to the August 2026 research update, protocols have been finalised, pilot data have been collected and ethical approval is being pursued.
The broader research programme also includes a pharmacological component designed to investigate how changes in GABA-related signalling affect brain activity and symptoms.
Why does this matter?
If researchers identify reproducible abnormalities in particular neurotransmitter systems, these findings could eventually inform the development of more targeted treatment studies.
But there is an important distinction between identifying a possible biological mechanism and demonstrating that a medication can improve symptoms.
Even if altered GABA or glutamate signalling is observed, this would not establish that medications acting on these systems are effective or safe treatments for VSS.
The planned pharmacological research is intended to investigate mechanisms, not to establish a new treatment.
Research update: King’s College London – Research Programme
5. Switzerland: Advanced MRI research remains open to participants
University of Zurich, Switzerland
Not every relevant study is newly launched. Some longer-running projects remain important because they continue to investigate unanswered questions.
In Zurich, researchers are using high-field MRI to study neurological conditions including migraine, epilepsy and VSS.
The project uses advanced imaging methods to examine brain structure, function and other measurable characteristics.
Comparing different neurological conditions may help researchers determine which findings are shared and which could be more specific to VSS.
What is the current status?
The study was first registered in 2022 and is therefore not a new research project from 2026.
Nevertheless, it remains listed as recruiting in recent research registry information.
That makes it potentially relevant to patients interested in participating, although the availability of places specifically for people with VSS must be confirmed with the research team.
The study involves in-person assessments in Switzerland. International participants should ask about eligibility, the number of visits required and possible reimbursement of expenses before considering travel.
Study information: ClinicalTrials.gov – NCT05524493
Other Research Worth Following
Not every registered or announced project represents a new development.
For example, a randomised controlled trial investigating MBCT-vision, an adapted mindfulness-based programme for people with VSS, remains listed as not yet recruiting. However, its public registration has not been updated since August 2023.
Without more recent confirmation from the researchers, it would be misleading to present this as a newly available participation opportunity.
The study is designed to investigate whether an eight-week programme can affect perceived visual symptom severity and daily functioning. It does not assume that VSS has a psychological cause.
MBCT-vision – ClinicalTrials.gov
Genetic research is another area to watch. King’s College London is working towards incorporating VSS-related questions into TwinsUK, a major British twin research cohort.
Such research could eventually help clarify the contributions of genetic and environmental factors. According to the 2026 research update, the project is still progressing through approval procedures.
These projects remain relevant, but their current stage should not be confused with confirmed new findings or open recruitment.
Want to Participate in VSS Research? Here’s What You Should Know
Participating in research can be a valuable way to contribute to scientific understanding, even when a study does not offer treatment.
However, the practical requirements deserve careful consideration, particularly for people whose symptoms affect their ability to travel or tolerate visually demanding environments.
Before applying, consider the following questions:
- Is the study genuinely recruiting? Public registries are not always updated immediately. Contact the research team to confirm that places are available.
- Can you participate from your country? Some studies accept international participants, while others have geographical restrictions.
- How many visits are required? A single appointment may be manageable for some patients, while repeated international travel may not be.
- What will participation involve? Ask about bright or moving visual stimuli, MRI scans, possible symptom aggravation and opportunities for breaks.
- Are expenses covered? A participation payment does not necessarily include travel or accommodation.
- Is it a treatment study? Many VSS projects investigate neurological mechanisms rather than testing therapies.
For patients with severe symptoms, it is also reasonable to ask whether adjustments are available, such as additional rest periods, reduced sensory stimulation or remote completion of certain assessments.
Participation should be based on informed consent, and patients should never feel obliged to take part if the demands are beyond their capabilities.
Where can you find more studies?
Search ClinicalTrials.gov for Visual Snow Syndrome
ClinicalTrials.gov provides information about registered studies, including their objectives, locations, eligibility criteria and reported recruitment status.
Keep in mind that a study appearing in a register does not necessarily mean it is currently accepting new participants.
What Would Meaningful Progress Actually Look Like?
The growing range of VSS research methods is encouraging, but scientific progress should not be measured simply by the number of projects underway.
Several important questions remain.
Can researchers identify neurological findings that consistently distinguish VSS from migraine and other conditions? Can subjective visual symptoms be measured reliably enough to evaluate changes over time? And if a particular brain mechanism is identified, can influencing it produce a meaningful and lasting improvement in patients’ lives?
These questions matter because understanding a neurological difference is not the same as establishing its cause. Likewise, changing brain activity through an experimental intervention does not automatically demonstrate clinical benefit.
For research findings to become useful in healthcare, they must be reproducible, independently validated and shown to have practical significance.
The developments highlighted in this article illustrate different stages of that process. Some researchers are refining methods to measure visual perception. Others are analysing neurological data or investigating potential biological mechanisms. A smaller number of projects are exploring interventions, but reliable evidence for effective VSS treatments remains limited.
The next major advance may not be a treatment itself. It could be a reliable way to measure the condition, identify meaningful differences between patients or determine which neurological mechanisms are most relevant.
Those discoveries would not immediately eliminate symptoms. But they could help answer a question that remains central to VSS research: which findings can eventually be translated into treatments that make a measurable difference to patients?
That is the progress worth watching.
Visual Snow Europe independently follows developments in Visual Snow Syndrome research, with particular attention to scientific evidence, clinical relevance and accessibility for patients.
Research information reviewed in November 2026. Recruitment statuses, study timelines and eligibility requirements may change. Patients should consult the original research sources and contact study teams directly before making participation arrangements.

